Model2 adjustment factors: further adjustment of cell type; chemotherapy regimen; presence or absence of metastasis; clinical stage; whether or not radiotherapy.
Model2 adjustment factors: further adjustment of cell type; chemotherapy regimen; whether or not metastasis; clinical phased; whether or not radiotherapy.